The angiome: a new concept in cancer biology

被引:8
作者
Blann, A. D. [1 ]
Ramcharan, K. S. [1 ,2 ]
Stonelake, P. S. [2 ]
Luesley, D. [3 ]
Lip, G. Y. H. [1 ]
机构
[1] Univ Birmingham, Dept Med, Haemostasis Thrombosis & Vasc Biol Unit, Ctr Cardiovasc Sci, Birmingham B18 7QH, W Midlands, England
[2] Russells Hall Hosp, Dept Surg, Dudley, England
[3] City Hosp, Dept Obstet & Gynaecol, Birmingham, W Midlands, England
关键词
ENDOTHELIAL GROWTH-FACTOR; VON-WILLEBRAND-FACTOR; CELL-ADHESION MOLECULE-1; SOLUBLE E-SELECTIN; PROGENITOR CELLS; TUMOR ANGIOGENESIS; SURROGATE MARKERS; PROGNOSTIC-SIGNIFICANCE; VONWILLEBRAND-FACTOR; THYMIDINE PHOSPHORYLASE;
D O I
10.1136/jcp.2011.088948
中图分类号
R36 [病理学];
学科分类号
100103 [病原生物学];
摘要
Angiogenesis is a key process in cancer biology, and justifies focus on the endothelium. Separate studies have looked at different aspects of angiogenesis and vascular biology, primarily focusing on certain laboratory and imaging techniques that generally reflect one particular aspect of the assessment of the endothelium. These techniques include the secretion/release of molecules (such as growth factors) into the plasma, by the presence of mature and progenitor endothelial cells themselves in the circulation, but also by examination of peripheral blood flow and the local circulation of the tumour, and cells of the tumour itself. However, a limitation of this approach is that these methods, although themselves being useful, have often been viewed in isolation and thus can provide only a part of the vascular picture. The authors submit that this approach is weak, and introduce 'the angiome' as a term which fuses several different aspects of endothelial and tumour biology into a single concept. The authors suggest that the adoption of the concept of the angiome will bring improved insights into angiogenesis and thus cancer cell biology. In justifying this concept, the authors review the current understanding of endothelial biology and the methods of its assessment, and hypothesise that a more multifactorial approach to the angiome will be a crucial determinant of outcomes of and treatment strategies for diseases, in particular anti-angiogenics for cancer therapy.
引用
收藏
页码:637 / 643
页数:7
相关论文
共 138 条
[1]
IMMUNOQUANTITATION OF FACTOR-VIII-RELATED ANTIGEN (VONWILLEBRAND-FACTOR ANTIGEN) IN PROSTATE-CANCER [J].
ABLIN, RJ ;
BARTKUS, JM ;
GONDER, MJ .
CANCER LETTERS, 1988, 40 (03) :283-289
[2]
Angiogenesis in primary and metastatic epithelial ovarian carcinoma [J].
Abulafia, O ;
Triest, WE ;
Sherer, DM .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1997, 177 (03) :541-547
[3]
Molecular regulation of angiogenesis and lymphangiogenesis [J].
Adams, Ralf H. ;
Alitalo, Kari .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2007, 8 (06) :464-478
[4]
Role of endothelial progenitors and other bone marrow-derived cells in the development of the tumor vasculature [J].
Ahn, G-One ;
Brown, J. Martin .
ANGIOGENESIS, 2009, 12 (02) :159-164
[5]
Alvarez AA, 1999, CLIN CANCER RES, V5, P587
[6]
Microvessel quantification in benign and malignant ovarian tumors [J].
Amis, S. J. ;
Coulter-Smith, S. D. ;
Crow, J. C. ;
Maclean, A. B. ;
Perrett, C. W. .
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2005, 15 (01) :58-65
[7]
Vandetanib, Designed to Inhibit VEGFR2 and EGFR Signaling, Had No Clinical Activity as Monotherapy for Recurrent Ovarian Cancer and No Detectable Modulation of VEGFR2 [J].
Annunziata, Christina M. ;
Walker, Amanda J. ;
Minasian, Lori ;
Yu, Minshu ;
Kotz, Herbert ;
Wood, Bradford J. ;
Calvo, Katherine ;
Choyke, Peter ;
Kimm, Daniel ;
Steinberg, Seth M. ;
Kohn, Elise C. .
CLINICAL CANCER RESEARCH, 2010, 16 (02) :664-672
[8]
Vascular endothelial growth factor overproduced by tumour cells acts predominantly as a potent angiogenic factor contributing to malignant progression [J].
Aonuma, M ;
Saeki, Y ;
Akimoto, T ;
Nakayama, Y ;
Hattori, C ;
Yoshitake, Y ;
Nishikawa, K ;
Shibuya, M ;
Tanaka, NG .
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY, 1999, 80 (05) :271-281
[9]
Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come [J].
Aref, S ;
El Sherbiny, M ;
Goda, T ;
Fouda, M ;
Al Askalany, H ;
Abdalla, D .
HEMATOLOGY, 2005, 10 (02) :131-134
[10]
Molecular magnetic resonance imaging with targeted contrast agents [J].
Artemov, D .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2003, 90 (03) :518-524